IonQ Faces Billion-Valuation Test After Tonight's Earnings
IonQ is set to report Q4 2025 earnings tonight, confronting a valuation that many analysts say risks outpacing the co...
Timing matters: automatic rebalancing should occur as your allocations drift beyond set thresholds.
18,157 articlesIonQ is set to report Q4 2025 earnings tonight, confronting a valuation that many analysts say risks outpacing the co...
Two bold moves by Eli Lilly are reshaping the billion-dollar obesity drug market. This guide breaks down what happene...
Institutional buyers are flocking to STRC, Strategy’s variable-rate perpetual preferred stock, driving an 11% yield a...
Trump’s tariff threat makes markets pivot, accelerating a rotation from U.S. stocks to international equities. The Va...
IonQ stunned traders with a sharp rally after reporting stronger-than-expected 2025 results and a robust 2026 revenue...
Unpack the essentials of fulgent genetics (flgt) earnings in plain language. This guide translates the earnings trans...
A potential U.S. strike on Iran could squeeze global oil supplies and push prices higher, forcing households and inve...
A new trend in real estate is quietly reshaping the market: houses are being delisted at higher rates. This delisting...
Bitcoin remains rangebound near the mid-$60,000s as geopolitical tensions rise and expectations for policy easing fad...
NVIDIA is signaling a bold push into faster AI inference with a new chip design. This move could reshape cloud comput...
Is Nike losing its spark in performance running? This article dives into whether nike lost edge performance and what ...
A divided fed signals rate-cut bets as doves likely push for easing this year. Markets are recalibrating as investors...